Third quarter 2025 net loss was $ (16.3) million, or $ (0.26) per share, compared to $ (15.4) million, or $ (0.25) per share, for the same period in 2024. Adjusted EBITDA loss was $ (2.6) million in ...
1 Non-GAAP cost of product revenues excludes the amortization of licensed intellectual property for Iclusig relating to the acquisition of the European business of ARIAD Pharmaceuticals, Inc. and the ...
1 Non-GAAP cost of product revenues excludes the amortization of licensed intellectual property for Iclusig relating to the acquisition of the European business of ARIAD Pharmaceuticals, Inc. and the ...
(*) Consists of charges to cost of revenues for the difference between the fair value of acquired inventory in business combination, which was recorded at fair value, and the actual cost of this ...
Meets or exceeds all third quarter guidance metrics GAAP Net income of $5.2 million reflects $35 million year-over-year improvement GAAP EPS of ...
U.S. GAAP gross profit is calculated as total revenues less U.S. GAAP cost of sales. U.S. GAAP gross margin is calculated as U.S. GAAP gross profit divided by total revenues. Adjusted gross profit is ...
The MarketWatch News Department was not involved in the creation of this content. Management uses certain non-GAAP metrics to evaluate our operating and financial results. The presentation of non-GAAP ...
E-commerce florist and gift retailer 1-800-FLOWERS (NASDAQ:FLWS) missed Wall Street’s revenue expectations in Q3 CY2025, with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback